Nonpartisan civic infrastructure

H.R. 3433

BillFederalHousePassed House

An Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.

About This Bill

Passed

Latest Action · September 24, 2024

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Congress

118th (2023–2025)

Introduced

May 17, 2023

Sponsor

Rep. Michael McCaulR

Cosponsors (235)

137D 98R

View PDF ↗

Summary Full Text Comments Annotations

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position

Add a comment

to comment on this bill.

Annotate the text

Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.